These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
292 related items for PubMed ID: 29632955
21. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation. Lee SY, Hur SH, Lee SG, Kim SW, Shin DH, Kim JS, Kim BK, Ko YG, Choi D, Jang Y, Hong MK. Circ Cardiovasc Interv; 2015 Feb; 8(2):e001878. PubMed ID: 25613674 [Abstract] [Full Text] [Related]
22. Optical coherence tomographic analysis of drug-eluting in-stent restenosis at different times: A STROBE compliant study. Feng C, Zhang P, Han B, Li X, Liu Y, Niu D, Shi Y. Medicine (Baltimore); 2018 Aug; 97(34):e12117. PubMed ID: 30142870 [Abstract] [Full Text] [Related]
24. Biological effect on drug distribution and vascular healing via paclitaxel-coated balloon technology in drug eluting stent restenosis swine model. Li Y, Tellez A, Rousselle SD, Dillon KN, Garza JA, Barry C, Granada JF. Catheter Cardiovasc Interv; 2016 Jul; 88(1):89-98. PubMed ID: 26613810 [Abstract] [Full Text] [Related]
25. Optical coherence tomography characteristics of in-stent restenosis after drug-eluting stent implantation: a novel classification and its clinical significance. Yamamoto W, Fujii K, Otsuji S, Takiuchi S, Kakishita M, Ibuki M, Hasegawa K, Ishibuchi K, Tamaru H, Yasuda S, Ishii R, Nakabayashi S, Kusumoto H, Higashino Y. Heart Vessels; 2020 Jan; 35(1):38-45. PubMed ID: 31250131 [Abstract] [Full Text] [Related]
27. In-stent neoatherosclerosis and tissue characteristics of restenotic lesions following implantation of second generation drug-eluting stents in unrestricted coronary lesions: Optical frequency domain imaging study. Sabbah M, Kadota K, El-Eraky A, Kamal HM, Abdellah AT, El Hawary A. J Interv Cardiol; 2017 Jun; 30(3):195-203. PubMed ID: 28295660 [Abstract] [Full Text] [Related]
29. Clinical and pathological characteristics of homogeneous and nonhomogeneous tissue of in-stent restenosis visualized by optical coherence tomography. Itoh T, Fusazaki T, Kimura T, Oikawa H, Sasou S, Ishikawa Y, Goto I, Komuro K, Nakajima S, Koeda Y, Kaneko K, Nishiyama O, Nakamura M, Morino Y. Coron Artery Dis; 2015 May; 26(3):201-11. PubMed ID: 25714072 [Abstract] [Full Text] [Related]
30. In-Stent Restenosis with "Inflammatory" Neointima Following Everolimus-Eluting Stent Implantation. Tsuji Y, Koide M, Katsura K, Fujita H, Ishibashi-Ueda H, Otsuka F. Int Heart J; 2018 Sep 26; 59(5):1142-1145. PubMed ID: 30012926 [Abstract] [Full Text] [Related]
31. Appearance of neointima according to stent type and restenotic phase: analysis by optical coherence tomography. Goto K, Takebayashi H, Kihara Y, Hagikura A, Fujiwara Y, Kikuta Y, Sato K, Kodama S, Taniguchi M, Hiramatsu S, Haruta S. EuroIntervention; 2013 Sep 26; 9(5):601-7. PubMed ID: 23518860 [Abstract] [Full Text] [Related]
33. [OCT analysis of in-stent neointima over 5 years post-DES implantation]. Han Y, Yuan XH, Jiang MT, Feng HH, Zhang X, Zhang YQ, Jing J, Chen YD, Gao L. Zhonghua Xin Xue Guan Bing Za Zhi; 2024 Feb 24; 52(2):150-157. PubMed ID: 38326066 [Abstract] [Full Text] [Related]
34. Incidence of late-acquired stent malapposition of drug eluting stents with second generation permanent and biodegradable polymer coatings-A prospective, randomized comparison using optical coherence tomography. Roth C, Gangl C, Dalos D, Delle-Karth G, Neunteufl T, Berger R. J Interv Cardiol; 2018 Dec 24; 31(6):780-791. PubMed ID: 30479028 [Abstract] [Full Text] [Related]
35. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials. Alfonso F, Pérez-Vizcayno MJ, García Del Blanco B, García-Touchard A, López-Mínguez JR, Masotti M, Zueco J, Melgares R, Mainar V, Moreno R, Domínguez A, Sanchís J, Bethencourt A, Moreu J, Cequier A, Martí V, Otaegui I, Bastante T, Gonzalo N, Jiménez-Quevedo P, Cárdenas A, Fernández C, under the auspices of the Interventional Cardiology Working Group of the Spanish Society of Cardiology. Circ Cardiovasc Interv; 2016 Jul 24; 9(7):. PubMed ID: 27412868 [Abstract] [Full Text] [Related]
37. Optical coherence tomography (OCT) in PCI for in-stent restenosis (ISR): rationale and design of the SEDUCE (Safety and Efficacy of a Drug elUting balloon in Coronary artery rEstenosis) study. Adriaenssens T, Dens J, Ughi G, Coosemans M, Onsea K, Dubois C, Sinnaeve P, Vrolix M, Desmet W. EuroIntervention; 2011 May 24; 7 Suppl K():K100-5. PubMed ID: 22027717 [Abstract] [Full Text] [Related]
38. Optical coherence tomography characteristics of in-stent restenosis are different between first and second generation drug eluting stents. Kilickesmez K, Dall'Ara G, Rama-Merchan JC, Ghione M, Mattesini A, Vinues CM, Konstantinidis N, Pighi M, Estevez-Loureiro R, Zivelonghi C, Lindsay AC, Secco GG, Foin N, De Silva R, Di Mario C. Int J Cardiol Heart Vessel; 2014 Jun 24; 3():68-74. PubMed ID: 29450174 [Abstract] [Full Text] [Related]
39. Mechanisms and Patterns of Intravascular Ultrasound In-Stent Restenosis Among Bare Metal Stents and First- and Second-Generation Drug-Eluting Stents. Goto K, Zhao Z, Matsumura M, Dohi T, Kobayashi N, Kirtane AJ, Rabbani LE, Collins MB, Parikh MA, Kodali SK, Leon MB, Moses JW, Mintz GS, Maehara A. Am J Cardiol; 2015 Nov 01; 116(9):1351-7. PubMed ID: 26341188 [Abstract] [Full Text] [Related]
40. In vivo optical coherence tomography of very late drug-eluting stent thrombosis compared with late in-stent restenosis. Miyazaki S, Hiasa Y, Takahashi T, Yano Y, Minami T, Murakami N, Mizobe M, Tobetto Y, Nakagawa T, Chen PM, Ogura R, Miyajima H, Yuba K, Hosokawa S, Kishi K, Ohtani R. Circ J; 2012 Nov 01; 76(2):390-8. PubMed ID: 22130319 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]